Mathieu Laversanne
Impact in
- Cancer Research top 0.01%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
Papers in
- Co-authors
- Freddie Bray (49 shared papers)Isabelle Soerjomataram (19 shared papers)Ahmedin Jemal (9 shared papers)Jacques Ferlay (14 shared papers)Hyuna Sung (5 shared papers)Rebecca L. Siegel (3 shared papers)Melina Arnold (9 shared papers)Jérôme Vignat (13 shared papers)
- Journals
- International Journal of Cancer (15 papers)JNCI Journal of the National Cancer Institute (4 papers)Cancer Epidemiology (4 papers)European Urology (3 papers)Cancer Epidemiology Biomarkers & Prevention (2 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Mathieu Laversanne
58 papers receiving 102.6k citations
Mathieu Laversanne's Hit Papers
Peers
Comparison fields: 5 of 212
- Cancer Research 15.1k
- Oncology 25.3k
- Pulmonary and Respiratory Medicine 18.3k
- Hepatology 3.8k
- Molecular Biology 27.2k
Countries citing papers authored by Mathieu Laversanne
This map shows the geographic impact of Mathieu Laversanne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Laversanne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Laversanne more than expected).
Fields of papers citing papers by Mathieu Laversanne
This network shows the impact of papers produced by Mathieu Laversanne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Laversanne. The network helps show where Mathieu Laversanne may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Laversanne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries Hit paper breakdown → | 2021 | 75060 |
| 2 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Hit paper breakdown → | 2024 | 12012 |
| 3 | Global patterns and trends in colorectal cancer incidence and mortality Hit paper breakdown → | 2016 | 3709 |
| 4 | Current and future burden of breast cancer: Global statistics for 2020 and 2040 Hit paper breakdown → | 2022 | 1906 |
| 5 | The ever‐increasing importance of cancer as a leading cause of premature death worldwide Hit paper breakdown → | 2021 | 1656 |
| 6 | Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN Hit paper breakdown → | 2022 | 1231 |
| 7 | Global burden of primary liver cancer in 2020 and predictions to 2040 Hit paper breakdown → | 2022 | 1214 |
| 8 | Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040 Hit paper breakdown → | 2022 | 736 |
| 9 | International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality Hit paper breakdown → | 2014 | 716 |
| 10 | The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020 Hit paper breakdown → | 2022 | 648 |
| 11 | The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study Hit paper breakdown → | 2022 | 448 |
| 12 | Cancer Hit paper breakdown → | 2015 | 446 |
| 13 | International trends in hepatocellular carcinoma incidence, 1978–2012 Hit paper breakdown → | 2019 | 410 |
| 14 | Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030 Hit paper breakdown → | 2017 | 311 |
| 15 | The Hit paper breakdown → | 2024 | 263 |
| 16 | 2016 | 262 | |
| 17 | 2015 | 250 | |
| 18 | 2017 | 241 | |
| 19 | 2015 | 232 | |
| 20 | Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012 Hit paper breakdown → | 2020 | 197 |
About Mathieu Laversanne
Mathieu Laversanne is a scholar working on Oncology, Surgery, Epidemiology, Pulmonary and Respiratory Medicine and Organizational Behavior and Human Resource Management, having authored 60 papers that have together received 103.7k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (16 papers), Colorectal Cancer Screening and Detection (9 papers), Liver Disease Diagnosis and Treatment (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Global Public Health Policies and Epidemiology (5 papers), Hepatitis B Virus Studies (4 papers), Testicular diseases and treatments (4 papers) and Esophageal Cancer Research and Treatment (4 papers). The work is most often cited by research in Cancer Research (15.1k citations), Oncology (25.3k citations), Pulmonary and Respiratory Medicine (18.3k citations), Hepatology (3.8k citations) and Molecular Biology (27.2k citations). Mathieu Laversanne has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Freddie Bray, Isabelle Soerjomataram, Ahmedin Jemal, Jacques Ferlay, Hyuna Sung, Rebecca L. Siegel, Melina Arnold, Jérôme Vignat, Mónica S. Sierra and Elisabete Weiderpass. Their work appears in journals such as International Journal of Cancer, JNCI Journal of the National Cancer Institute, Cancer Epidemiology, European Urology and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.